Do weight loss pills work as well as injections? What the evidence says

How the trial numbers compare across oral and injectable options

The most useful place to start is the published evidence, because the debate about pills versus injections often outruns the data. The STEP 1 trial, published in the New England Journal of Medicine, found that weekly injectable semaglutide 2.4 mg produced an average weight reduction of around 15% over 68 weeks. For the oral version of the same molecule, the OASIS 4 phase-3 trial (307 adults with obesity or overweight, 64 weeks, versus placebo) found an average reduction of roughly 13.6%: a smaller figure but still well above what lifestyle changes alone typically produce. Among participants who stayed fully adherent to treatment, that figure reached about 17%.

Tirzepatide injections (Mounjaro) sit above both in the evidence base. SURMOUNT-1 randomised 2,539 adults and reported average body-weight reductions of around 20–21% at the highest dose over 72 weeks. That single dataset shifts the conversation considerably. It is the reason NICE, when appraising tirzepatide in Technology Appraisal TA1026, concluded it offered greater average benefit than semaglutide.

So in raw population averages: injectable tirzepatide leads, injectable semaglutide sits behind it, and the oral semaglutide tablet currently trails both. But population averages are not individual predictions. Someone who finds weekly injections unworkable and therefore stops treatment after a few months will not replicate a trial number. Adherence is not a footnote; it is part of the result.

Why the pill produces a smaller number, and why that gap may narrow

Oral semaglutide uses the same active molecule as the injection, but getting it absorbed through the gut wall is genuinely difficult. Wegovy tablets are co-formulated with an absorption enhancer (SNAC) and must be taken first thing in the morning on an empty stomach, swallowed whole with a small amount of plain water, then followed by a 30-minute wait before any food, drink or other medicines. That strict ritual exists because even a sip of coffee or a concurrent tablet can blunt absorption significantly. The lower average weight-loss figure, compared with the injection, partly reflects this bioavailability challenge rather than the molecule being inherently weaker.

There is a practical upside. No refrigeration is required: the tablet travels without an ice pack, sits in a bag or on a bedside table, and removes the question of injection technique entirely. For people who genuinely cannot manage a weekly injection, the pill offers a licensed, clinically supported alternative that did not exist in the UK before June 2026.

Whether the gap between oral and injectable results narrows at higher doses or with better formulations in future is an active research question. For now, the approved Wegovy tablet escalates from 1.5 mg through 4 mg and 9 mg to a 25 mg maintenance dose, with at least a month at each step, and if you are weighing up the two formats it is worth reading whether weight loss tablets work as well as injections before deciding, because the maintenance dose does produce meaningful, sustained weight reduction in the clinical data.

What 'working as well' actually means for a real person

A question our prescribers hear most weeks is some version of: 'If the pill works less well, why would I choose it?' The answer is that 'working less well on average across a trial population' and 'wrong for this person' are different statements. A 13–17% average weight reduction is substantial by any clinical measure. For someone whose weight-related blood pressure is the primary concern, or whose lifestyle makes injections genuinely impractical, the oral route may be the one they actually stick with, and sticking with treatment is what produces results.

The factors that shift a prescriber's recommendation include: phobia of needles or injections, travel patterns (some people tell us a Monday order before a holiday feels simpler with a tablet that travels at room temperature), existing medicines and how they interact, and whether previous GLP-1 treatment has been tried. The mechanism behind weight-loss injections and oral GLP-1 medicines is closely related: both slow gastric emptying, reduce appetite signals and influence blood sugar regulation. The delivery route changes; the underlying biology does not.

On the question of cost, the honest picture is that injectable and oral options sit in a similar price range in the private market, though this varies by dose and provider. If you want to understand what drives pricing across routes, our guide to how weight-loss injection costs are structured covers that clearly. Neither route should be bought without a prescription from a registered prescriber, the MHRA has warned publicly about fake and substandard pens and tablets sold online, and the risks of unverified sources are real.

Which option might be right for you, and how to find out

Neither pills nor injections are automatically the better choice. The evidence currently favours injectable tirzepatide for average weight reduction at the population level, but if you are still uncertain it helps to look carefully at whether injections or pills are better for weight loss given your own circumstances, because the licensed oral option is clinically meaningful and, for many people, practically superior. Both require a prescription. Both require a prescriber to assess your medical history, current medicines, BMI and weight-related conditions before any treatment is started.

Private licensed eligibility for weight-management GLP-1 medicines broadly covers adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, raised cholesterol or type 2 diabetes; lower thresholds apply for some ethnic backgrounds under UK guidance. BMI alone does not determine approval. A prescriber looks at the whole picture.

At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, the same working day) not processed by an algorithm. You can read more about how we work on our about page, or explore the full range of weight-loss treatments we offer. If you have questions before you start, our FAQs cover the most common ones, including whether weight loss pills are as effective as injections.

If you think a licensed weight-loss medicine could help, the right next step is a clinical assessment. Check your eligibility with our prescribers through a free consultation.